Decline of measles-specific immunoglobulin M antibodies after primary measles, mumps, and rubella vaccination

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 2, 1998, Pages 135-138

  Helfand, Rita F ^a,b,e   Gary Jr , Howard E ^b   Atkinson, William L ^c   Nordin, James D ^d   Keyserling, Harry L ^a   Bellini, William J ^b  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTERS FOR DIS CONTR AND PREV   (United States)

^d Group Health Foundation   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; MEASLES MUMPS RUBELLA VACCINE;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEASLES VACCINATION; MUMPS; PRESCHOOL CHILD; PRIORITY JOURNAL; RUBELLA; TREATMENT OUTCOME;

EID: 0031947853     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.2.135-138.1998     Document Type: Article

References (8)

1. Atkinson, W., L. Markowitz, A. Baughman, B. Sullivan, J. Nordin, J. Heath, D. Erdman, A. Nelson, and P. Patricia. 1992. Response to measles revaccination among children who fail to respond to the first dose of measles vaccine, abstr. 421, p. 181. In Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
2. Centers for Disease Control and Prevention. 1997. Case definitions for infectious conditions under public health surveillance. Morbid. Mortal. Weekly Rep. 46RR-10:1-64.
3. Centers for Disease Control and Prevention. Unpublished data.
4. Erdman, D., L. Anderson, D. Adams, J. Stewart, L. Markowitz, and W. Bellini. 1991. Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J. Clin. Microbiol. 29:1466-1471.
5. Helfand, R. F., J. L. Heath, L. J. Anderson, E. F. Maes, D. Guris, and W. J. Bellini. 1997. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J. Infect. Dis. 175:195-199.
6. Hummel, K., D. Erdman, J. Heath, and W. Bellini. 1992. Baculovirus expression of the nuclcoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J. Clin. Microbiol. 30:2874-2880.
7. Markowitz, L. E., and S. L. Katz. 1994. Measles vaccine, p. 229-276. In S. A. Plotkin and E. A. Mortimer (ed.), Vaccines. W. B. Saunders, Philadelphia. Pa.
8. Redd, S. C., M. Wharton, and R. Helfand. 1996. Measles, p. 2:50-2:67. In Manual for the surveillance of vaccine-preventable diseases. Centers for Disease Control and Prevention, Atlanta, Ga.